Earlier today I looked at how successful small cap investing can be if you can identify a start of the future.
With that in mind, I thought I would pick out several small cap shares which I believe have significant potential and could generate outsized returns for investors in the future.
Here are four small cap shares to watch:
Alcidion Group Ltd (ASX: ALC)
Alcidion is an informatics solutions company to watch in the 2020s. It provides software which aims to improve the efficacy and cost of delivering services to patients and reduce hospital-acquired complications. I feel it is well placed for growth thanks to the growing trend for healthcare organisations to shift to a paperless environment.
Bigtincan Holdings Ltd (ASX: BTH)
Bigtincan is a provider of enterprise mobility software. Its software allows sales and service organisations to increase their sales win rates, reduce costs, and improve customer satisfaction through improved mobile worker productivity. Last year Bigtincan added to its blue chip customer base with agreements with sports giant Nike and global beauty retailer Sephora. I believe this is a testament to the quality of its product and bodes well for its performance in FY 2020 and beyond.
Opthea Ltd (ASX: OPT)
Another small cap to watch is Opthea. It is a developer of novel biologic therapies for the treatment of eye diseases. Last year the Phase 2b study of its OPT-302 combination therapy delivered exceptionally strong results. If its phase 3 results are equally successful, OPT-302 could generate significant revenues. Current standard of care treatments for wet age-related macular degeneration and diabetic macular edema had sales of over US$3.7 billion and US$6.2 billion in 2018.
Volpara Health Technologies Ltd (ASX: VHT)
A final small cap to watch is Volpara. It is a provider of software that uses artificial intelligence imaging algorithms to assist with the early detection of breast and lung cancer. The software continues to grow in popularity with radiologists across North America, leading to its recurring revenues increasing at a rapid rate. I expect this positive trend to continue this year, especially given its recent acquisitions.
